FDA Warns Against Combining Remdesivir And Hydroxychloroquine
Video Credit: Wochit - Duration: 00:31s - Published
FDA Warns Against Combining Remdesivir And Hydroxychloroquine
The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19.
The warning cautions against administering hydroxychloroquine in combination with remdesivir.
According to Reuters, the agency said the co-administration may result in the reduced effectiveness of remdesivir.
Remdesivir is currently the only medication to show benefits against COVID-19 in clinical trials.
The warning comes hours after the FDA revoked emergency permission to use hydroxychloroquine to treat COVID-19.
![Trump Criticizes FDA Over Hydroxychloroquine Decision [Video]](https://video.newsserve.net/300/v/20200616/1308306132-Trump-Criticizes-FDA-Over-Hydroxychloroquine-Decision.jpg)
